Assay+ COVID-19 antigen rapid test is authorized with CE marker, the sensitivity is 90%, the specificity is 98.5%. Assay+ Covid 19 antigen rapid test is a lateral flow immunochromatographic assay intended for the qualitative detection of the nucleocapsid protein of SARS-CoV-2 from the nasopharyngeal swab from the suspected COVID-19 patients within five days of symptom onset. This test is an aid to differentiate Covid 19 virus infection from other respiratory tract infection caused by coronavirus 229E, NL63, OC43 and HKU1, or severe acute respiratory syndrome caused by SARS-CoV and MERS-CoV. The test should be performed in moderate, high or waived complexity tests. This test can also perform for the Point of Care (POC) purpose.
Assay+ Syphilis ntibody rapid test is manufactured in Canada to detect specific syphilis IgG for the healthcare providers. Assay+ syphilis Rapid Test Kit is qualitative test device for syphilis antibodies from human serum or plasma,. This device has been OEM over one million for our customers. Sensitivity over 95% syphilis infected patients, and 100% specificity have been proved used by our customers in large quantity.
Assay+ HBV surface antigen rapid test is manufactured in Canada to detect HBV surface antigen for the healthcare providers. Assay+ HBV surface antigen Rapid Test Kit is qualitative test device for HBV antigen in human serum, plasma, whole blood. This device has been used by our end customers with large quantity. Sensitivity over 95% and 100% specificity have been proved used by our customers in large quantity.
Diagnostic rapid test product, diagnostic reagent, recombinant protein, polyclonal and monoclonal antibody.
Covid 19 test kit, dengue rapid test, syphilis rapid test and pregnancy rapid test and others.